HealthcarePress Releases

Platelet Rich Plasma Market Size To Reach US$ 715.65 million by 2030

Share This Article

The platelet rich plasma market is expected to grow at a CAGR of 11.6% during forecast period 2021 to 2030and is projected to reach around US$ 715.65 million by 2030.

The platelet rich plasma market report covers a detailed analysis for the historic period 2017-2020, considering 2021 as the base year and forecast (growth) for 2021-2030.

Download Free Sample Copy with TOC, Graphs & List of Figures @ https://www.precedenceresearch.com/sample/1237

This research report evaluates the platelet rich plasma market on a global and regional level. It offers a thorough analysis of the market revenue status, growth, future trends, and forecast of the global platelet rich plasma market for the period from 2017 to 2030.

Growth Factors

Rising elderly population and intensifying orthopedic conditions are probable to lift the growth of global platelet rich plasma market. As per data published by National Center for Biotechnology Information, more than 1.4 million people are recognized with fractures related to osteoporosis every year. Besides, escalating attentiveness associated to platelet rich plasma therapy for dental treatment is likely to boost the market expansion.

Research and Development in drug delivery system for platelet-rich bioactive molecules is anticipated to propose profitable development prospects for companies operational in the global platelet-rich plasma market. For example, in 2020, researchers from Czech Republic, Charles University, and Institute of Experimental Medicine of the Czech Academy of Sciences stated development of an easy delivery system to extend the effects of the bioactive molecules released by platelets.

PRP comprise 7 growth factors, and it can be employed for numerous treatments, including severe ligament, and muscle wounds, chronic tendon wounds, knee arthritis, surgery, pain and fractures. In orthopedics, the usage of PRP is likely to upsurge over the year to come. Due to cumulative elderly populace, incidence of doctor-diagnosed arthritis is predictable to surge suggestively within prediction period. The popularity of PRP is on the escalation, still its true efficiency is yet to be completely recognized. The PRP is extensively utilized in surgery to recover torn knee ligaments, like the anterior circulate ligament. The PRP eases the rapid curing of the tissue afterward surgical actions.

Market Report Scope

Report Highlights Details
Market Size USD 715.65 Million by 2030
Growth Rate CAGR of 11.6% From 2021 to 2030
Base Year 2020
Historic Data 2017 to 2020
Forecast Period 2021 to 2030
Segments Covered Product, Origin, Application
Regional Scope North America, Europe, Asia Pacific, Latin America, Middle East & Africa (MEA)

For More Information or Customization Before Buying, Visit @ https://www.precedenceresearch.com/customization/1237

This report enables readers to make important decisions with regard to their business, with the help of a wealth of Information enclosed in the study. The report also provides the compound annual growth rate (CAGR) of the global platelet rich plasma market for the forecast period of 2021–2030. This data can help readers interpret quantitative growth aspects of the global market during the forecast period. It presents a wealth of information on key market dynamics, including drivers, market trends, and challenges, as well as the structure of the global market across the globe.

The report analyzes the historical and present-day scenario of the global platelet rich plasma market to accurately gauge its growth potential. The study presents detailed information about important growth factors, restraints, and key trends that are creating the landscape for growth of the global market in order to identify opportunities for stakeholders.

Key Highlights

  • International market participants like Harvest, Cesca, Biomet and Arthrex are reinforcing their prevailing distribution networks to augment their market footprint and revenue share
  • Among different applications, Orthopedics segment help majority of the market share in terms of revenue in 2019. This is on account of the fact that number of orthopedic problems such as quadriceps, rotator cuff, Achilles tendon injuries, hamstring, and tennis elbow can be treated effectively with PRP
  • North America gathered major revenue cut in the global platelet-rich plasma market due to occurrence of noteworthy players who are functioning in the field of PRP market.
  • Asia Pacific is anticipated to exhibit rapid growth throughout assessment duration. Cumulative number of cosmetic surgeries to improve facial features in nations such as Thailand, Korea, and India are projected to boost growth of the market in this region.

Purchase Full Research Report (Single User License US$ 4500) @ https://www.precedenceresearch.com/checkout/1237

Competition Landscape

In the final section of the research report, Precedence Research provided the global platelet rich plasma market structure and a detailed competition landscape to provide a dashboard view of key players operating in the global market along with their business strategies to report audiences. This section is primarily designed to provide clients with an objective and detailed comparative assessment of the key providers specific to a market segment in the value chain of the market.

Some of the major players in the platelet rich plasma market include:

  • Zimmer Biomet
  • Arthrex, Inc.
  • Harvest Technologies Corporation
  • Stryker Corporation
  • DePuy Synthes, Inc.
  • Cesca Therapeutics, Inc.
  • AdiStem Ltd.
  • Exactech Inc.
  • ISTO Biologics
  • Nuo Therapeutics

Market Segmentation

By Product

  • Leukocyte Rich PRP
  • Pure PRP
  • Leukocyte Rich Fibrin

By Origin

  • Allogeneic PRP
  • Autologous PRP
  • Homologous PRP

By Application

  • Cosmetic Surgery & Dermatology
  • Orthopedic Surgery
  • General Surgery
  • Ophthalmic Surgery
  • Neurosurgery
  • Other

Regional Segmentation

– North America (U.S. and Canada)

 – Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)

 – Asia-Pacific (China, Japan, India, Southeast Asia and Rest of APAC)

 – Latin America (Brazil and Rest of Latin America)

– Middle East and Africa (GCC, North Africa, South Africa, Rest of MEA)

Research Methodology

  • Market estimate for 2020
  • Average selling price (ASP) per region for specific product type
  • Filtrations and assortment of gathered data, to estimate the base year (2021) market size for the country
  • Gathering data from company websites, annual reports, white papers, financial reports, broker reports, investor presentations, and SEC filings
  • National government documents, statistical databases
  • News articles, press releases, and webcasts specific to companies operating in the market
  • Country wise analysis through internal and external proprietary databases, and relevant patent and regulatory databases
  • Determination of market penetration by country

Most Asked Questions –

What was the market size value of the platelet rich plasma in 2020?

What is the expected market size by 2030?

What is the platelet rich plasma market growth?

What are the key factors that positively influence market growth?

Who are the prominent players in the platelet rich plasma market?

Why Buy this Report?

The purpose of Precedence Research’s platelet rich plasma market study is to provide stakeholders with a detailed picture of potential barriers and untapped opportunities. The report contains exclusive information to assist businesses in making informed decisions about how to maintain growth throughout the assessment period.

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective
1.2. Scope of the Study
1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach
2.2. Data Sources
2.3. Assumptions& Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Platelet Rich Plasma Market Variables and Scope

4.1. Introduction
4.2. Market Classification and Scope

Chapter 5. COVID 19 Impact on Platelet Rich Plasma Market

5.1. Covid-19: Platelet Rich Plasma Industry Impact
5.2. Platelet Rich Plasma Business Impact Assessment: Covid-19
5.2.1. Services Challenges/Disruption
5.2.2. Market Trends and Platelet Rich Plasma Opportunities in the COVID-19 Landscape for Major Markets
5.3. Strategic Measures against Covid-19
5.3.1. Government Support and Initiative to Combat Covid-19
5.3.2. Proposal for Platelet Rich Plasma Market Players to deal with Covid-19 Pandemic Scenario

Chapter 6. Platelet Rich Plasma Market Dynamics Analysis and Trends

6.1. Market Dynamics
6.1.1. Market Drivers
6.1.1.1. Intensifying elderly population and mounting pervasiveness of orthopedic situtaions
6.1.1.2. Growing applications of platelet-rich plasma products in hair transplant and other cosmetic applications
6.1.2. Market Restraints
6.1.2.1. Restraint 1
6.1.3. Market Opportunities
6.1.3.1. Opportunity 1
6.1.3.2. Opportunity 2

Chapter 7. Global Platelet Rich Plasma Market: Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis
7.1.1.1. Platelet Rich Plasma Market Revenue by Market Players (2015-2020)
7.1.1.2. Platelet Rich Plasma Market Revenue Market Share by Market Players (2015-2020)
7.1.2. Key Organic/Inorganic Strategies Adopted by Players
7.1.2.1. Product Portfolio Expansion, Geographic Expansion, Product Innovation
7.1.2.2. Merger and Acquisition, Collaboration and Partnerships
7.1.3. Market Players Landscape
7.1.3.1. List of Product Type Suppliers
7.1.3.2. List of End-users

Chapter 8. Global Platelet Rich Plasma Market, By Product Type

8.1. Platelet Rich Plasma Market, by Component, 2016-2030
8.1.1. Leukocyte Rich PRP
8.1.1.1. Market Revenue and Forecast (2016-2030)
8.1.2. Pure PRP
8.1.2.1. Market Revenue and Forecast (2016-2030)
8.1.3. Leukocyte Rich Fibrin
8.1.3.1. Market Revenue and Forecast (2016-2030)

Chapter 9. Global Platelet Rich Plasma Market, By Application

9.1. Platelet Rich Plasma Market, by Application, 2016-2030
9.1.1. Allogeneic PRP
9.1.1.1. Market Revenue and Forecast (2016-2030)
9.1.2. Autologous PRP
9.1.2.1. Market Revenue and Forecast (2016-2030)
9.1.3. Homologous PRP
9.1.3.1. Market Revenue and Forecast (2016-2030)

Chapter 10. Global Platelet Rich Plasma Market, By End-user

10.1. Platelet Rich Plasma Market, by End-user, 2016-2030
10.1.1. Cosmetic Surgery & Dermatology
10.1.1.1. Market Revenue and Forecast (2016-2030)
10.1.2. Orthopedic Surgery
10.1.2.1. Market Revenue and Forecast (2016-2030)
10.1.3. General Surgery
10.1.3.1. Market Revenue and Forecast (2016-2030)
10.1.4. Ophthalmic Surgery
10.1.4.1. Market Revenue and Forecast (2016-2030)
10.1.5. Neurosurgery
10.1.5.1. Market Revenue and Forecast (2016-2030)
10.1.6. Others
10.1.6.1. Market Revenue and Forecast (2016-2030)

Chapter 11. Global Platelet Rich Plasma Market, Regional Estimates and Trend Forecast

11.1. North America
11.1.1. Market Revenue Forecast by Product Type(2016-2030)
11.1.2. Market Revenue Forecast by Application (2016-2030)
11.1.3. Market Revenue Forecast by End-user (2016-2030)
11.1.4. U.S
11.1.4.1. Market Revenue Forecast (2016-2030)
11.1.5. Canada
11.1.5.1. Market Revenue Forecast (2016-2030)
11.2. Europe
11.2.1. Market Revenue Forecast by Product Type(2016-2030)
11.2.2. Market Revenue Forecast by Application (2016-2030)
11.2.3. Market Revenue Forecast by End-user (2016-2030)
11.2.4. UK
11.2.4.1. Market Revenue Forecast (2016-2030)
11.2.5. Germany
11.2.5.1. Market Revenue Forecast (2016-2030)
11.2.6. France
11.2.6.1. Market Revenue Forecast (2016-2030)
11.2.7. Rest of EU
11.2.7.1. Market Revenue Forecast (2016-2030)
11.3. Asia Pacific (APAC)
11.3.1. Market Revenue Forecast by Product Type(2016-2030)
11.3.2. Market Revenue Forecast by Application (2016-2030)
11.3.3. Market Revenue Forecast by End-user (2016-2030)
11.3.4. China
11.3.4.1. Market Revenue Forecast (2016-2030)
11.3.5. India
11.3.5.1. Market Revenue Forecast (2016-2030)
11.3.6. Japan
11.3.6.1. Market Revenue Forecast (2016-2030)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue Forecast (2016-2030)
11.4. LATAM
11.4.1. Market Revenue Forecast by Product Type(2016-2030)
11.4.2. Market Revenue Forecast by Application (2016-2030)
11.4.3. Market Revenue Forecast by End-user (2016-2030)
11.4.4. Brazil
11.4.4.1. Market Revenue Forecast (2016-2030)
11.4.5. Rest of LATAM
11.4.5.1. Market Revenue Forecast (2016-2030)
11.5. Middle East and Africa (MEA)
11.5.1. Market Revenue Forecast by Product Type(2016-2030)
11.5.2. Market Revenue Forecast by Application (2016-2030)
11.5.3. Market Revenue Forecast by End-user (2016-2030)
11.5.4. GCC
11.5.4.1. Market Revenue Forecast (2016-2030)
11.5.5. North Africa
11.5.5.1. Market Revenue Forecast (2016-2030)
11.5.6. South Africa
11.5.6.1. Market Revenue Forecast (2016-2030)
11.5.7. Rest of MEA
11.5.7.1. Market Revenue Forecast (2016-2030)

Chapter 12. Company Profiles

12.1. Zimmer Biomet
12.1.1. Company Overview, Business Information, Regional Presence
12.1.2. Product Portfolio Analysis
12.1.2.1. Product Details, Specification, Application
12.1.3. Revenue, Price, and Gross Margin (2015-2020)
12.1.4. Recent Developments and Strategies
12.2. Arthrex, Inc.
12.2.1. Company Overview, Business Information, Regional Presence
12.2.2. Product Portfolio Analysis
12.2.2.1. Product Details, Specification, Application
12.2.3. Revenue, Price, and Gross Margin (2015-2020)
12.2.4. Recent Developments and Strategies
12.3. Harvest Technologies Corporation
12.3.1. Company Overview, Business Information, Regional Presence
12.3.2. Product Portfolio Analysis
12.3.2.1. Product Details, Specification, Application
12.3.3. Revenue, Price, and Gross Margin (2015-2020)
12.3.4. Recent Developments and Strategies
12.4. Stryker Corporation
12.4.1. Company Overview, Business Information, Regional Presence
12.4.2. Product Portfolio Analysis
12.4.2.1. Product Details, Specification, Application
12.4.3. Revenue, Price, and Gross Margin (2015-2020)
12.4.4. Recent Developments and Strategies
12.5. DePuy Synthes, Inc.
12.5.1. Company Overview, Business Information, Regional Presence
12.5.2. Product Portfolio Analysis
12.5.2.1. Product Details, Specification, Application
12.5.3. Revenue, Price, and Gross Margin (2015-2020)
12.5.4. Recent Developments and Strategies
12.6. Cesca Therapeutics, Inc.
12.6.1. Company Overview, Business Information, Regional Presence
12.6.2. Product Portfolio Analysis
12.6.2.1. Product Details, Specification, Application
12.6.3. Revenue, Price, and Gross Margin (2015-2020)
12.6.4. Recent Developments and Strategies
12.7. AdiStem Ltd.
12.7.1. Company Overview, Business Information, Regional Presence
12.7.2. Product Portfolio Analysis
12.7.2.1. Product Details, Specification, Application
12.7.3. Revenue, Price, and Gross Margin (2015-2020)
12.7.4. Recent Developments and Strategies
12.8. Exactech Inc.
12.8.1. Company Overview, Business Information, Regional Presence
12.8.2. Product Portfolio Analysis
12.8.2.1. Product Details, Specification, Application
12.8.3. Revenue, Price, and Gross Margin (2015-2020)
12.8.4. Recent Developments and Strategies
12.9. ISTO Biologics
12.9.1. Company Overview, Business Information, Regional Presence
12.9.2. Product Portfolio Analysis
12.9.2.1. Product Details, Specification, Application
12.9.3. Revenue, Price, and Gross Margin (2015-2020)
12.9.4. Recent Developments and Strategies
12.10. Nuo Therapeutics
12.10.1. Company Overview, Business Information, Regional Presence
12.10.2. Product Portfolio Analysis
12.10.2.1. Product Details, Specification, Application
12.10.3. Revenue, Price, and Gross Margin (2015-2020)
12.10.4. Recent Developments and Strategies

Chapter 13. Appendix

13.1. About Us
13.2. Glossary of Terms

Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or the Asia Pacific.

Purchase Full Research Report (Single User License US$ 4500) @ https://www.precedenceresearch.com/checkout/1237

About Us

Precedence Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace & defense, among different ventures present globally.

Contact Us:         

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Email: sales@precedenceresearch.com

For Latest Update Follow Us:

https://www.linkedin.com/company/precedence-research/

https://www.facebook.com/precedenceresearch/

https://twitter.com/Precedence_R

Show More

Precedence Research

Precedence Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings.

Related Articles

Back to top button